$GERN Recent News Baker Hughes, Halliburton gain on

New Post Public Reply Private Reply Replies (0) Message Board

Dec 7, 2014 at 11:51 PM

$GERN Recent News

Baker Hughes, Halliburton gain on potential merger; Fossil in red 10:07 a.m. Nov. 14, 2014 - Sue Chang
Looming $40 crude and how to vape your way to profits 5:47 a.m. Nov. 14, 2014 - Shawn Langlois
Baker Hughes shares rise on possible buyout 6:02 p.m. Nov. 13, 2014 - Wallace Witkowski
Herbalife shares drop after hours as earnings disappoint 6:58 p.m. Nov. 3, 2014 - Wallace Witkowski
Geron's stock soars after FDA lifts hold on new drug application 7:48 a.m. Nov. 3, 2014 - Tomi Kilgore
Geron's stock jumps 35% premarket after FDA lifts hold on new drug application 7:35 a.m. Nov. 3, 2014 - Tomi Kilgore
FDA places hold on Geren's Imetelstat application 7:25 a.m. March 12, 2014 - MarketWatch.com
Charting the latest market whipsaw 10:59 a.m. Nov. 11, 2013 - Michael Ashbaugh
Oracle active, Geron shares fall after hours 6:06 p.m. Dec. 3, 2012 - Carla Mozee
Geron to discontinue brain-cancer drug development 4:38 p.m. Dec. 3, 2012 - MarketWatch.com
BioTime offers equity stake for Geron assets 8:47 a.m. Oct. 18, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 1:42 p.m. Sept. 10, 2012 - MarketWatch
Geron ends breast cancer study of Imetelstat 7:06 a.m. Sept. 10, 2012 - MarketWatch.com
Stocks to Watch Friday: Splunk, Zumiez, Pandora 3:59 p.m. Aug. 30, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 3:31 p.m. Aug. 30, 2012 - MarketWatch
Geron climbs 11% on analyst rating 9:56 a.m. Aug. 30, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:37 p.m. Nov. 15, 2011 - Kate Gibson
Financial uncertainty nixed Geron stem cell work 2:09 p.m. Nov. 15, 2011 - MarketWatch.com
Stocks to watch Friday: Global Crossing, Clarcor 5:42 a.m. Sept. 30, 2011 - MarketWatch
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy

Geron (GERN) Stock: Moving Average Crossover Alert - Tale of the Tape 9:47 a.m. Dec. 5, 2014 - Zacks.com
BioTime Harnesses Geron's Stem Cell Technology And Its Founder; Is That Enough To Survive The Biotech Revolution? 10:51 a.m. Dec. 3, 2014 - Seeking Alpha
Geron (GERN) Showing Signs Of A Dead Cat Bounce Today 10:10 a.m. Nov. 26, 2014 - TheStreet.com
Strong On High Relative Volume: Geron (GERN) 10:01 a.m. Nov. 21, 2014 - TheStreet.com
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape 8:43 a.m. Nov. 19, 2014 - Zacks.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal 10:40 a.m. Nov. 17, 2014 - TheStreet.com
Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape 9:25 a.m. Nov. 17, 2014 - Zacks.com
Geron Collaborates with J&J for Imetelstat - Analyst Blog 6:00 p.m. Nov. 14, 2014 - Zacks.com
Geron's Short Squeeze Is Here 3:40 p.m. Nov. 14, 2014 - Seeking Alpha
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline 3:36 p.m. Nov. 14, 2014 - TheStreet.com
Midday Gainers From November 14: Geron, Pandora Media, Bitauto, IAMGOLD 11:44 a.m. Nov. 14, 2014 - benzinga.com
What Licensing Imetelstat Will Mean for Geron 10:45 a.m. Nov. 14, 2014 - 247WallSt.com
Geron (GERN) Is Today's Pre-Market Mover With Heavy Volume Stock 9:04 a.m. Nov. 14, 2014 - TheStreet.com
Morning Market Movers 8:39 a.m. Nov. 14, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:03 a.m. Nov. 14, 2014 - benzinga.com
Geron wins deal to develop blood disorder drug, could get $935M 5:55 p.m. Nov. 13, 2014 - Seeking Alpha
Geron Licenses Experimental Myelofibrosis Drug to Johnson & Johnson 4:34 p.m. Nov. 13, 2014 - TheStreet.com
Geron's Risk/Reward Profile Improves As Near-Term Uncertainty Ends 1:06 p.m. Nov. 7, 2014 - Seeking Alpha

Geron to Host Analyst and Investor Meeting on December 8 9:31 p.m. Dec. 5, 2014 - Thomson Reuters ONE
Geron Announces Publication of Preclinical Data on Imetelstat Activity in Acute Myelogenous Leukemia 4:16 p.m. Dec. 4, 2014 - Thomson Reuters ONE
Geron to Present at the 26th Annual Piper Jaffray Healthcare Conference 4:16 p.m. Nov. 26, 2014 - Thomson Reuters ONE
Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 9:00 a.m. Nov. 18, 2014 - PR Newswire - PRF
Geron to Present at the Stifel Healthcare Conference 4:16 p.m. Nov. 14, 2014 - Thomson Reuters ONE
Geron Announces Global Strategic Collaboration with Janssen to Develop and Commercialize Imetelstat 4:16 p.m. Nov. 13, 2014 - Thomson Reuters ONE
Geron Announces Presentations at American Society of Hematology Annual Meeting 9:15 a.m. Nov. 6, 2014 - Thomson Reuters ONE
Geron Announces Removal of Full Clinical Hold on Imetelstat IND 7:31 a.m. Nov. 3, 2014 - Thomson Reuters ONE
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
GERON SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors In Geron Corporation's January 2014 Offering To Contact The Firm 3:00 p.m. Oct. 10, 2014 - PR Newswire - PRF
Biotech Equities Technical Review -- Celldex Therapeutics, Synthetic Biologics, Geron, Catalyst Pharmaceutical Partners, and NPS Pharmaceuticals 8:15 a.m. Sept. 8, 2014 - PR Newswire - PRF
Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 6:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Geron Corporation Reports Second Quarter 2014 Financial Results 3:06 p.m. Aug. 11, 2014 - Thomson Reuters ONE
Geron to Assume Sponsorship of Myelofibrosis IST and IND 6:30 a.m. Aug. 5, 2014 - Thomson Reuters ONE
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Geron Announces Conference Call to Discuss Second Quarter 2014 Financial Results 6:31 a.m. July 30, 2014 - Thomson Reuters ONE
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 6:30 a.m. June 26, 2014 - PR Newswire - PRF
Sales, Clinical Hold Removal, Trial Initiations, and Committee Recommendations - Analyst Notes on Geron, Zalicus, Northwest Biotherapeutics, Progenics and TG Therapeutics 4:30 a.m. June 17, 2014 - PR Newswire - PRF
Geron Reports Removal of Partial Clinical Hold on Myelofibrosis IST 4:01 a.m. June 12, 2014 - Thomson Reuters ONE
Intersect ENT Announces Appointment of Chief Financial Officer Jeryl Hilleman 7:03 a.m. June 4, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Millrose Faces Class Action: Blame Game in Motion

Millrose Properties: A Realty Ruckus Unfolding Sometimes, in the world of stocks, it feels like you're two steps ahead of the scam or already knee-deep in trouble. Millrose Properties, Inc. struck a rather sour chord recently with an 8.53% stock drop, leaving investors feeling the burn. Here's the juice: a securities fraud class action is in motion, and if you're holding...

Mili and Egnyte Transform Financial Advice Delivery

AI Powers Up Financial Advisors with New Partnership Ah, the grind never ends for those financial advisors, right? Well, here's a nugget that might just lighten their load. Mili and Egnyte are buddying up to merge AI with secure content platforms, aiming to supercharge how advisors handle client documents. Right off the bat, advisors can crank out personalized advice at a...

Hemlo Mining's Q3 2026: Challenges and New Solutions

Resilience in the Face of Operational Setbacks Here's a peek into Hemlo Mining's latest exploits. They're riding a rollercoaster of operational challenges, yet still managing to chug along with stable gold production. It's like trying to drive uphill with a flat tire, but somehow, Hemlo's trucking along without missing too much of a beat. The numbers are in, and despite a...

Dan-O's Seasoning Bags $25M to Spice Up Global Kitchens

Spicing Up The Investment Scene Who would've thought a humble seasoning mix could steal the show in the investment world, eh? Dan-O's Seasoning, that quirky little flavor brand from Louisville, just pulled a $25 million rabbit out of the hat with an investment from The Newcastle Network. That's news worth chewing on. From Farmers Market to Flavor Giant Let's flash back a...

Equity Alerts: Unraveling the Latest M&A Surprises

Diving Into the M&A Controversy On the bustling streets of New York, beneath the towering Empire State Building, a plot unfolds that could shake the foundations of your investments—particularly if you're holding shares in Synaptics, Eagle Financial, Victory Capital, or Centerspace. Juan Monteverde and his legal firepower from Monteverde & Associates PC are launching a...

Minesto Joins Sweden-Indonesia Partnership in Energy Shift

Minesto's Big Splash in Indonesia's Energy Transition Here we go, folks. Minesto's taking the plunge into Indonesia's uncharted tidal waters under a Sweden-backed partnership. This Swedish underdog in ocean energy is ready to shake things up and ride the Indonesian currents, thanks to the Sweden-Indonesia Sustainability Partnership. Now, why should this matter to you, the...

Microencapsulation Market to Hit $24B by 2031

Think about wrapping a tiny gift inside a bubble that's not only protective but also dissolves at just the right moment. That, my friends, is microencapsulation summed up—and it's becoming a big deal. With the market poised to jump from $16.90 billion in 2026 to a whopping $24.02 billion by 2031, at a steady clip of 7.3% annually, there's a lot for investors to chew on...

European Flavors: A Halloween Food Revolution

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

New American Perspectives Shines at HIFF 2026

Ever notice how the arts can cut through the noise and spotlight voices we often overlook? Well, that's exactly what's happening at the Hawai?i International Film Festival (HIFF) this year. The Vilcek Foundation, alongside HIFF, is bringing the New American Perspectives program back for another round at the festival’s 46th edition, and it's a heck of a lineup....

Highlight's Pulse Offers Real-Time Consumer Insights

Highlight Introduces Pulse for Instant Insights Ever find yourself waiting forever for consumer feedback? Well, folks, Highlight's making sure those days are behind us with their new launch: Pulse. They've taken the conventional consumer testing model and flipped it on its head with Highlight Twins. Imagine getting the pulse of your audience in mere seconds, not the...